InvestorsHub Logo
Followers 33
Posts 2991
Boards Moderated 1
Alias Born 10/24/2015

Re: None

Saturday, 11/30/2024 7:47:09 PM

Saturday, November 30, 2024 7:47:09 PM

Post# of 288
CTX130 data in R/R T-cell lymphomas (peripheral T-cell lymphoma or cutaneous T-cell lymphoma) https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00508-4/abstract

The ORR was 46.2%. Of those treated at DL3 and higher, the ORR was 51.6%.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRSP News